Phase 1 Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
Price : $35 *
At a glance
- Drugs Cytokine-induced killer cell therapy (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Alliancells-PuRui Bioscience
- 31 Aug 2018 Biomarkers information updated
- 15 Apr 2015 Planned End Date changed from 1 Jun 2014 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
- 15 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.